Shringar House of Mangalsutra Ltd (SHRINGARMS) — share price & stock analysis
Profits have nearly tripled in two years.
Shringar House of Mangalsutra Ltd (SHRINGARMS) trades at ₹224 as of 1 July 2026. The machine reads this as steady growth: profits have nearly tripled in two years. the price is in Stage 4 — declining, 10 weeks in; the business cycle reads STEADY / EXPANSION. Fundamentals-momentum score: 87/100 (mostly improving).
Data as of 1 July 2026 · every number traces to its Screener source column · not investment advice.
- Market cap
- ₹2,164 Cr
- P/E
- 18.7×
- ROE
- 26.3%
- Book value / share
- ₹70.3
- Revenue (FY26)
- ₹2,246 Cr
- Profit after tax (FY26)
- ₹115 Cr
- Weinstein stage
- Stage 4 (10 weeks)
- Data as of
- 1 July 2026
This is a steady business by its own record — profit dips never exceeded 5% across 6 years. The cycle matters less than execution here.net_profit
Where the clock stands now: earnings sit at 100% of their historical range, margins are the best ever printed, and valuation history is thin. That reads as EXPANSION — the comfortable middle — but the records are already on the table; from here the bet is that they keep coming.net_profit
3 of the 4 things we track are currently moving the right way — nearly everything is pulling in the same direction.
Where the levels actually stand: ROCE 27% — a high-quality engine; effectively no debt; margins at an all-time high. Momentum says which way things are moving; these say where they are.
Read this number for what it is: it measures the DIRECTION of change, not the quality of the business. A mediocre business getting better scores high here; a great one having a soft quarter scores low. Profit, sales and margins count double, and a quarter of the score comes from our earnings-recovery lens (is the profit cycle turning up off its trough?).
The price is in a downtrend — fighting it is expensive
STAGE 4 · DECLINING · 10 WEEKSStock prices move through four repeating stages: basing (1), advancing (2), topping (3) and declining (4). This one is in Stage 4: declining, 10 weeks in.stage
The price is below its falling 200-day average — history says most of the damage in stocks happens here. Cheap can get cheaper in Stage 4.dma_200
What would end it: two Friday closes in a row below the 200-day line. That is the house exit rule — mechanical, no debates.dma_200
Data: Weekly price, moving averages and stage
| Period | Price (₹) | 200-DMA (₹) | 50-DMA (₹) | Stage |
|---|---|---|---|---|
| Sep 25 | 190 | 185 | 185 | 4 |
| Sep 25 | 184 | 185 | 186 | 4 |
| Oct 25 | 188 | 185 | 186 | 4 |
| Oct 25 | 212 | 186 | 189 | 4 |
| Oct 25 | 197 | 187 | 191 | 4 |
| Oct 25 | 214 | 188 | 193 | 2 |
| Oct 25 | 225 | 189 | 198 | 2 |
| Nov 25 | 224 | 191 | 202 | 2 |
| Nov 25 | 216 | 192 | 205 | 2 |
| Nov 25 | 225 | 193 | 208 | 2 |
| Nov 25 | 223 | 195 | 211 | 2 |
| Dec 25 | 219 | 196 | 213 | 2 |
| Dec 25 | 197 | 196 | 211 | 2 |
| Dec 25 | 220 | 197 | 211 | 2 |
| Dec 25 | 226 | 198 | 213 | 2 |
| Jan 26 | 240 | 200 | 216 | 2 |
| Jan 26 | 231 | 202 | 220 | 2 |
| Jan 26 | 244 | 203 | 221 | 2 |
| Jan 26 | 222 | 204 | 223 | 2 |
| Feb 26 | 215 | 205 | 222 | 2 |
| Feb 26 | 220 | 206 | 222 | 2 |
| Feb 26 | 237 | 207 | 225 | 2 |
| Feb 26 | 246 | 209 | 230 | 2 |
| Feb 26 | 234 | 211 | 232 | 2 |
| Mar 26 | 211 | 211 | 230 | 2 |
| Mar 26 | 193 | 211 | 225 | 2 |
| Mar 26 | 190 | 210 | 219 | 2 |
| Mar 26 | 181 | 209 | 213 | 2 |
| Apr 26 | 176 | 208 | 209 | 2 |
| Apr 26 | 192 | 207 | 205 | 2 |
| Apr 26 | 202 | 206 | 204 | 2 |
| Apr 26 | 202 | 206 | 204 | 2 |
| Apr 26 | 202 | 206 | 204 | 4 |
| May 26 | 226 | 206 | 205 | 4 |
| May 26 | 207 | 206 | 206 | 4 |
| May 26 | 213 | 207 | 206 | 4 |
| May 26 | 210 | 207 | 207 | 4 |
| Jun 26 | 209 | 207 | 208 | 4 |
| Jun 26 | 209 | 207 | 208 | 4 |
| Jun 26 | 204 | 207 | 208 | 4 |
| Jun 26 | 211 | 207 | 207 | 4 |
| Jun 26 | 214 | 207 | 208 | 4 |
| Jun 26 | 214 | 207 | 209 | 4 |
| Jun 26 | 215 | 207 | 209 | 1 |
| Jun 26 | 217 | 207 | 209 | 4 |
| Jul 26 | 224 | 208 | 210 | 4 |
5 of 5 years up since listing — good compounding, but a short book
Over 5 years, sales went from ₹510 Cr to ₹2,246 Cr (about 35% a year), and profit from ₹13.0 Cr to ₹115 Cr.revenuenet_profit
Margins widened 3 points along the way — growth with improving economics.operating_profit
Data: Revenue by year
| Period | Revenue (₹ Cr) |
|---|---|
| FY21 | 510 |
| FY22 | 810 |
| FY23 | 950 |
| FY24 | 1,102 |
| FY25 | 1,430 |
| FY26 | 2,246 |
Data: Profit by year
| Period | Profit after tax (₹ Cr) |
|---|---|
| FY21 | 13 |
| FY22 | 20 |
| FY23 | 23 |
| FY24 | 31 |
| FY25 | 61 |
| FY26 | 115 |
Data: OPM % by year
| Period | OPM % (%) |
|---|---|
| FY21 | 4.1 |
| FY22 | 3.7 |
| FY23 | 4.0 |
| FY24 | 4.5 |
| FY25 | 6.4 |
| FY26 | 7.1 |
Sales exploded 107% last quarter — the 4th straight quarter of growth
Mar 26 sales were ₹726 Cr, up 107% on the same quarter last year.revenue
That makes 4 quarters of growth in a row — this is a trend, not a blip.revenue
Data: Quarterly sales
| Period | Revenue (₹ Cr) | YoY growth (%) |
|---|---|---|
| Jun 24 | 271 | – |
| Sep 24 | 416 | – |
| Dec 24 | 391 | – |
| Mar 25 | 351 | – |
| Jun 25 | 333 | 22.9 |
| Sep 25 | 529 | 27.2 |
| Dec 25 | 659 | 68.5 |
| Mar 26 | 726 | 106.8 |
Margins have been rebuilt — 3.7% in FY22 to 7.1% now
Of every ₹100 of sales, the company keeps ₹6.2 as operating profit (a year ago it kept ₹6.6).opm_pct
Zoom out and this is the page's quiet hero: annual operating margin bottomed at 3.7% in FY22 and has been rebuilt to 7.1% — that recovery, not sales alone, is what powers the profit growth elsewhere on this page.operating_profit
Data: Three margins, quarterly
| Period | Gross (%) | Operating (%) | Net (%) |
|---|---|---|---|
| Jun 24 | 11.3 | 9.3 | 6.3 |
| Sep 24 | 7.1 | 5.9 | 3.9 |
| Dec 24 | 6.6 | 5.0 | 3.3 |
| Mar 25 | 8.2 | 6.6 | 4.3 |
| Jun 25 | 14.6 | 12.4 | 8.6 |
| Sep 25 | 8.4 | 6.2 | 4.3 |
| Dec 25 | 8.3 | 6.1 | 4.6 |
| Mar 26 | 8.9 | 6.2 | 4.7 |
Profit exploded 127% — mostly from selling more
Mar 26 profit after tax was ₹34.0 Cr, up 127% year on year.net_profit
Data: Quarterly profit after tax
| Period | PAT (₹ Cr) | YoY growth (%) |
|---|---|---|
| Jun 24 | 17.0 | – |
| Sep 24 | 16.0 | – |
| Dec 24 | 13.0 | – |
| Mar 25 | 15.0 | – |
| Jun 25 | 29.0 | 70.6 |
| Sep 25 | 23.0 | 43.8 |
| Dec 25 | 30.0 | 130.8 |
| Mar 26 | 34.0 | 126.7 |
The single biggest driver was selling more.
Data: Where the profit change came from (Mar 25 → Mar 26)
| Component | Effect (₹ Cr) |
|---|---|
| PAT Mar 25 | 15 |
| More sales | +25 |
| Thinner margins | −3 |
| Other income | +2 |
| Tax | −5 |
| PAT Mar 26 | 34 |
Profits on paper, cash lagging behind
Over the last 5 profitable years, the business reported ₹250 Cr of profit and collected ₹−320 Cr of operating cash — about -128% conversion.operating_cash_flownet_profit
The wrinkle is the latest year: FY26 collected ₹−282 Cr against ₹115 Cr of reported profit — about -245%. One year isn’t a trend, but it is the line to watch.operating_cash_flownet_profit
The gap sits in receivables: customers now take 38 days to pay, up from 22. Profit booked, cash pending.debtor_days
Data: Cash collected vs profit reported (annual)
| Period | Operating cash flow (₹ Cr) | Profit after tax (₹ Cr) |
|---|---|---|
| FY21 | -5.0 | 13.0 |
| FY22 | -30.0 | 20.0 |
| FY23 | 13.0 | 23.0 |
| FY24 | -14.0 | 31.0 |
| FY25 | -7.0 | 61.0 |
| FY26 | -282 | 115 |
The cash cycle is stretching — more money stuck in the pipeline
One rupee now takes about 116 days to go out the door as materials and come back as collected cash — up from 74 days the year before.cash_conversion_cycle
The biggest mover: customers taking longer to pay (22 → 38 days).debtor_days
Data: Days of cash locked up (annual)
| Period | Customers owe (debtor days) (days) | Stock on shelf (inventory days) (days) | We owe suppliers (payable days) (days) |
|---|---|---|---|
| FY21 | 14.0 | 47.0 | 14.0 |
| FY22 | 12.0 | 54.0 | 3.0 |
| FY23 | 18.0 | 43.0 | 1.0 |
| FY24 | 20.0 | 51.0 | 3.0 |
| FY25 | 22.0 | 64.0 | 12.0 |
| FY26 | 38.0 | 79.0 | 2.0 |
The asset base keeps compounding — this company builds
The productive asset base has gone from ₹15.0 Cr (FY21) to ₹65.0 Cr.fixed_assetscwip
The build is bigger than the cash engine: investing outflows (₹108 Cr) exceeded operating cash (₹−303 Cr) over the last 3 years — the difference comes from debt or shareholders.investing_cash_flowoperating_cash_flow
Data: Assets in place vs under construction (annual)
| Period | Fixed assets (₹ Cr) | Under construction (CWIP) (₹ Cr) |
|---|---|---|
| FY21 | 15.0 | 0.0 |
| FY22 | 51.0 | 0.0 |
| FY23 | 52.0 | 0.0 |
| FY24 | 50.0 | 0.0 |
| FY25 | 50.0 | 0.0 |
| FY26 | 65.0 | 0.0 |
Debt is small — but no longer zero, and growing
For every ₹100 shareholders have put in (and left in), the company has borrowed ₹28 — total borrowings have grown from ₹23.0 Cr to ₹189 Cr over the window.borrowings
The equity base grew even faster, so the ratio stays comfortable — but a 8× rise in absolute borrowings deserves a name (acquisitions, capex), not a shrug. Watch whether it keeps compounding.borrowings
Data: Total borrowings (annual)
| Period | Borrowings (₹ Cr) |
|---|---|
| FY21 | 23.0 |
| FY22 | 98.0 |
| FY23 | 93.0 |
| FY24 | 110 |
| FY25 | 123 |
| FY26 | 189 |
Data: Debt vs shareholders’ money (annual)
| Period | Debt ÷ equity (x) |
|---|---|
| FY21 | 0.4 |
| FY22 | 1.2 |
| FY23 | 0.9 |
| FY24 | 0.8 |
| FY25 | 0.6 |
| FY26 | 0.3 |
Every ₹100 kept in the business earns ₹27 — a high-quality engine
Return on capital employed is 27.0% (a year ago: 32.0%). This is the single best test of business quality: what the company earns on the money it keeps.roce_pct
Data: Returns on capital (annual)
| Period | ROCE (%) |
|---|---|
| FY22 | 24.0 |
| FY23 | 20.0 |
| FY24 | 22.0 |
| FY25 | 32.0 |
| FY26 | 27.0 |
Worth studying deeper — with eyes open
The numbers lean positive, and the price is roughly fair to the delivery so far.
Best thing in the data: profit rising (₹15.0 Cr → ₹34.0 Cr).net_profit
Biggest worry: cash generation falling (₹−7.0 Cr → ₹−282 Cr).operating_cash_flow
Machine-written research from Screener data — every number traces to its source column. Sector Alpha is not a SEBI-registered investment adviser; nothing here is a recommendation to buy or sell. Not investment advice.
Straight answers from the data
What does Shringar House of Mangalsutra Ltd do?
Incorporated in January 2009, Shringar House of Mangalsutra Limited manufactures and designs Mangalsutra in India.[1]. It is listed in the Diamond, Gems & Jewellery sector with a market capitalisation of ₹2,164 Cr.
What is Shringar House of Mangalsutra Ltd's share price?
As of 1 July 2026, Shringar House of Mangalsutra Ltd trades at ₹224, with a market capitalisation of ₹2,164 Cr. Prices are weekly closes from Screener data; this page refreshes with each weekly update.
What is Shringar House of Mangalsutra Ltd's share price target?
Sector Alpha does not publish broker-style price targets. Our discounted-cash-flow model estimates Shringar House of Mangalsutra Ltd's intrinsic value at ₹534 per share under base assumptions (bear ₹173, bull ₹534), against the current price of ₹224 — a 146% margin of safety. The current price already implies roughly 9% annual earnings growth. These are model estimates, not forecasts — treat them as one input alongside the valuation history below, not as a target.
What did Shringar House of Mangalsutra Ltd report in its latest quarterly results?
In its most recent reported quarter (Q4 FY26, quarter ended March 2026): Mar 26 sales were ₹726 Cr, up 107% on the same quarter last year. Mar 26 profit after tax was ₹34.0 Cr, up 127% year on year. Figures are from Screener-scraped quarterly filings; the page updates when the next quarter is filed.
Is Shringar House of Mangalsutra Ltd growing?
Sales exploded 107% last quarter — the 4th straight quarter of growth. Mar 26 sales were ₹726 Cr, up 107% on the same quarter last year.
Are Shringar House of Mangalsutra Ltd's profits growing?
Profit exploded 127% — mostly from selling more. Mar 26 profit after tax was ₹34.0 Cr, up 127% year on year.
What are Shringar House of Mangalsutra Ltd's operating margins?
Margins have been rebuilt — 3.7% in FY22 to 7.1% now. In the most recent quarter, of every ₹100 of sales, the company keeps ₹6.2 as operating profit (a year ago it kept ₹6.6).
What is Shringar House of Mangalsutra Ltd's long-term growth record?
Revenue grew from ₹510 Cr in FY21 to ₹2,246 Cr in FY26 — a 34.5% compound annual growth rate over 5 years. Profit after tax compounded at 54.7% over the same period (₹13 Cr → ₹115 Cr).
Is Shringar House of Mangalsutra Ltd stock in an uptrend?
The price is in a downtrend — fighting it is expensive. Shringar House of Mangalsutra Ltd is in Stage 4 — declining, 10 weeks in (pending). Stages follow Stan Weinstein's four-phase read of weekly price against the 200-day average: basing (1), advancing (2), topping (3), declining (4).
Where is Shringar House of Mangalsutra Ltd in its business cycle?
The data reads Shringar House of Mangalsutra Ltd as a steady business currently in its expansion phase — earnings at an all-time high for this company. This is a steady business by its own record — profit dips never exceeded 5% across 6 years. The cycle matters less than execution here.
Does Shringar House of Mangalsutra Ltd have too much debt?
Debt is small — but no longer zero, and growing. For every ₹100 shareholders have put in (and left in), the company has borrowed ₹28 — total borrowings have grown from ₹23.0 Cr to ₹189 Cr over the window.
What is the bull case for Shringar House of Mangalsutra Ltd?
Profits have nearly tripled in two years. Best thing in the data: profit rising (₹15.0 Cr → ₹34.0 Cr). Sales exploded 107% last quarter — the 4th straight quarter of growth.
What is the bear case for Shringar House of Mangalsutra Ltd — what could break the story?
Biggest worry: cash generation falling (₹−7.0 Cr → ₹−282 Cr). Two quarters of profit reversing would kill this story. The nearest-term thing to watch: if quarterly growth slips below 53%, the story weakens. This falsification condition is stated up front so the thesis can be checked against incoming quarters, not defended after the fact.
Is Shringar House of Mangalsutra Ltd a stock worth studying right now?
Sector Alpha does not publish buy or sell recommendations — this is a research read, not advice. What the data says: worth studying deeper — with eyes open. The numbers lean positive, and the price is roughly fair to the delivery so far. Across the 7-model scorecard the composite research signal is study deeper at 81% confidence. This is machine-written research compiled from Screener data — every number traces to its source — and it is not investment advice. Do your own diligence.